Eyes may have natural anti-angiogenic response
The vitreous of eyes with retinal or choroidal neovascularisation appear to have higher levels of both pro-angiogenic factors and anti-angiogenic factors compared to eyes without the neovascularisations, according to a new study. The study involved 29 patients from whom vitreous samples were obtained in order to quantify the angiogenesis-associated proteins present via enzyme-linked immunosorbent assays. The researchers found that vitreous levels of the anti-angiogenic VEGF receptor 1 (sVEGFR-1) were significantly higher in eyes with AMD with CNV and in eyes with proliferative diabetic retinopathy than in control eyes. In addition, the concentrations of the anti-angiogenic protein, pigment epithelium-derived factor (PEDF) were decreased and that of proangiogenic angiopoietin 2 were increased. The authors concluded that higher amounts of sVEGFR-1 may point to activation of an endogenous anti-angiogenic system in the protein network.Â
•  (Huber et al Ophthalmologica 2012 (DOI: 10.1159/000339952.) Â
Latest Articles
Addressing Postoperative Visual Complications
Managing aberrations after laser refractive surgery requires a multi-layered approach.
3D Printing Helps Transform Ukrainian Eye Care
The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.
Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation
Emerging Microbial Trends That Could Affect Your Practices
A triptych of challenges paints a concerning picture for ophthalmologists across the globe.
Improving Outcomes with Laser-Assisted Surgery
Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.
Could the Corneal Transplant Pool Increase?
Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.
Matching Premium IOLs to Visual Lifestyles
From monofocal to full-range solutions, each practice needs comprehensive understanding.
Going Dutch on Acanthamoeba Keratitis
A world-first trial suggests a new medication could beat the disease.
Avoiding Intracorneal Ring Segment Complications
Femtosecond lasers are helping improve refractive results with fewer problems.